Altogether these results reveal that the cancer stem-cell potential of FN-RMS cells relays on ERK activation and, given the radioresistance phenotype might be the reason of cancer relapse, radiosensitivity induced by ERK inhibition could offer a promising therapy for FN-RMS patients (Figure 2). This evidence concerns the gene EPHB2 and cancer.